Better vitrectomy settings using donated blood
This trial studies how to improve a procedure called vitrectomy, which is a surgery to remove the gel inside the eye. It uses left-over blood samples from healthy donors to fine-tune equipment settings, and does not involve any treatment or extra procedures for participants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old.
- You must be in good general health and eligible for routine blood donation.
- You must be willing to sign a consent form for research use of your blood samples.
- Any condition that would normally prevent you from donating blood would also exclude you from this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects retina fluid samples from people getting treatment for a vitreoretinal disease. It aims to find better ways to understand and manage these conditions.
This study collects and stores blood/blood-cell samples so researchers can use them for approved future studies. You would be tested for certain infections and health measurements to make sure the collection procedure is safe for you.
This study collects tissue or blood samples from adults (and some healthy volunteers) to help researchers learn more and plan future studies. If you qualify, your samples may be used to test new ideas related to your health or for exploratory research.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
This study collects and stores blood and eye-related medical information to help researchers better understand retinal diseases, including age-related macular degeneration and diabetic retinopathy. Your samples may also be used to compare people with retinal disease to people without it.
This study compares two types of blood-derived treatments (a growth-factor enriched plasma product versus your own serum) to see which helps corneal cells heal better in people with aniridia. It may be helpful if you need improved cornea healing, but you must meet blood-safety and eye-sample requirements.
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.